Health Condition 1: null- Newly Diagnosed or recurrent Leukemia
Conditions
Interventions
None listed
Sponsors
Mazumdar Shaw Medical Center
APT Life Sciences India Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: -Newly Diagnosed and recurrent Leukemia - Willing to provide informed consent
Exclusion criteria
Exclusion criteria: -Patients with the history of heart diseases. e.g., NYHA Functional Class III or IV heart failure, Myocardial Infarction within 6 months , ventricular tachyarrhythmias requiring ongoing treatment, or unstable angina, or heart rhythm disorder -Patients with the history of psychological problems that would preclude participation in the study(like confusion, hallucination, loss of balance, change in the way you walk or talk, decreased). -Patients for whom, in the opinion of the investigator, their general status would not permit the administration of chemotherapy -Inability of the patient or Legally Acceptable Representative to give the informed consent. -Patients who are participating in another clinical trial currently.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To Assess Marrow concentration of blast cells.Timepoint: -At baseline -At 6 weeks follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| To identify patient-specific adjuvants and/or alternative drugs in leukemic patients.Timepoint: After Pecaso Analysis | — |
Countries
India
Contacts
Public ContactDr Anitha S
Narayana Health Hospitals
Outcome results
None listed